Baird Medical Valuation
| BDMD Stock | 0.80 0.03 4.47% |
Today, the firm appears to be overvalued. Baird Medical Investment shows a prevailing Real Value of USD0.74 per share. The current price of the firm is USD0.8044. Our model approximates the value of Baird Medical Investment from analyzing the firm fundamentals such as Return On Equity of -0.0803, profit margin of (0.1) %, and Current Valuation of 48.67 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Baird Medical's valuation include:
Price Book 0.7946 | Enterprise Value | Enterprise Value Ebitda 74.8416 | Price Sales 0.8876 | Enterprise Value Revenue 1.5276 |
Overvalued
Today
Please note that Baird Medical's price fluctuation is abnormally volatile at this time. Calculation of the real value of Baird Medical Investment is based on 3 months time horizon. Increasing Baird Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Baird stock is determined by what a typical buyer is willing to pay for full or partial control of Baird Medical Investment. Since Baird Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Baird Stock. However, Baird Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.8 | Real 0.74 | Hype 0.75 |
The real value of Baird Stock, also known as its intrinsic value, is the underlying worth of Baird Medical Investment Company, which is reflected in its stock price. It is based on Baird Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Baird Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Baird Medical Investment helps investors to forecast how Baird stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Baird Medical more accurately as focusing exclusively on Baird Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Baird Medical's intrinsic value based on its ongoing forecasts of Baird Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Baird Medical's closest peers. If more than one evaluation category is relevant for Baird Medical we suggest using both methods to arrive at a better estimate.
Baird Medical Cash |
|
About Baird Medical Valuation
The stock valuation mechanism determines Baird Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Baird Medical. We calculate exposure to Baird Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Baird Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 37.6 M | 25.2 M | |
| Pretax Profit Margin | 0.34 | 0.22 | |
| Operating Profit Margin | 0.41 | 0.48 | |
| Net Profit Margin | 0.30 | 0.17 | |
| Gross Profit Margin | 1.01 | 0.95 |
Baird Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Baird Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.6 M | |
| Quarterly Earnings Growth Y O Y | -0.003 |
Baird Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Baird Medical Investment and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Baird we look at many different elements of the entity such as Baird's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Baird Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Baird Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Baird Medical's worth.Complementary Tools for Baird Stock analysis
When running Baird Medical's price analysis, check to measure Baird Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baird Medical is operating at the current time. Most of Baird Medical's value examination focuses on studying past and present price action to predict the probability of Baird Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baird Medical's price. Additionally, you may evaluate how the addition of Baird Medical to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |